Implementation of isoniazid preventive therapy for people living with HIV worldwide: barriers and solutions

被引：85

作者：

Getahun, Haileyesus ^{[1
]}

Granich, Reuben ^{[2
]}

Sculier, Delphine ^{[1
]}

Gunneberg, Christian ^{[1
]}

Blanc, Leopold ^{[1
]}

Nunn, Paul ^{[1
]}

Raviglione, Mario ^{[1
]}

机构：

[1] WHO, Stop TB Dept, CH-1211 Geneva 27, Switzerland

[2] WHO, HIV AIDS Dept, CH-1211 Geneva 27, Switzerland

来源：

AIDS | 2010年 / 24卷

关键词：

barrier; HIV; INH; isoniazid preventive therapy; prevention; solution; Tuberculosis; LATENT TUBERCULOSIS INFECTION; SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; SOUTH-AFRICA; MORTALITY; ADULTS; PROPHYLAXIS; PREVALENCE; TRIAL; RISK;

D O I：

10.1097/01.aids.0000391023.03037.1f

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：S57 / S65

页数：9

共 62 条

[21] Screening people living with HIV before tuberculosis preventative therapy [J].

Godfrey-Faussett, P ;

Quigley, M ;

Ayles, H ;

Mwinga, A ;

Hosp, M ;

Porter, J .

AIDS, 1999, 13 (15) :2190-2191

[22] The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil [J].

Golub, Jonathan E. ;

Saraceni, Valeria ;

Cavalcante, Solange C. ;

Pacheco, Antonio G. ;

Moulton, Lawrence H. ;

King, Bonnie S. ;

Efron, Anne ;

Moore, Richard D. ;

Chaisson, Richard E. ;

Durovni, Betina .

AIDS, 2007, 21 (11) :1441-1448

[23] Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort [J].

Golub, Jonathan E. ;

Pronyk, Paul ;

Mohapi, Lerato ;

Thsabangu, Nkeko ;

Moshabela, Mosa ;

Struthers, Helen ;

Gray, Glenda E. ;

McIntyre, James A. ;

Chaisson, Richard E. ;

Martinson, Neil A. .

AIDS, 2009, 23 (05) :631-636

[24] A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis [J].

Gordin, FM ;

Matts, JP ;

Miller, C ;

Brown, LS ;

Hafner, R ;

John, SL ;

Klein, M ;

Vaughn, A ;

Besch, CL ;

Perez, G ;

Szabo, S ;

ElSadr, W .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (05) :315-320

[25] PREVALENCE OF TUBERCULIN POSITIVITY AND SKIN-TEST ANERGY IN HIV-1-SEROPOSITIVE AND HIV-1-SERONEGATIVE INTRAVENOUS-DRUG-USERS [J].

GRAHAM, NMH ;

NELSON, KE ;

SOLOMON, L ;

BONDS, M ;

RIZZO, RT ;

SCAVOTTO, J ;

ASTEMBORSKI, J ;

VLAHOV, D .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (03) :369-373

[26] Why have trials of isoniazid preventive therapy among people with HIV infection not demonstrated an effect on mortality? Did close examination of the trees obscure our view of the wood? [J].

Grant, Alison D. ;

Fielding, Katherine L. ;

Charalambous, Salome ;

Chaisson, Richard E. ;

Churchyard, Gavin J. .

AIDS, 2010, 24 :S15-S18

[27] Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection [J].

Halsey, NA ;

Coberly, JS ;

Desormeaux, J ;

Losikoff, P ;

Atkinson, J ;

Moulton, LH ;

Contave, M ;

Johnson, M ;

Davis, H ;

Geiter, L ;

Johnson, E ;

Huebner, R ;

Boulos, R ;

Chaisson, RE .

LANCET, 1998, 351 (9105) :786-792

[28] Costs of measures to control tuberculosis/HIV in public primary care facilities in Cape Town, South Africa [J].

Hausler, Harry Peter ;

Sinanovic, Edina ;

Kumaranayake, Lilani ;

Naidoo, Pren ;

Schoeman, Hennie ;

Karpakis, Barbara ;

Godfrey-Faussett, Peter .

BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2006, 84 (07) :528-536

[29] Opportunities and challenges for HIV care in overlapping HIV and TB epidemics [J].

Havlir, Diane V. ;

Getahun, Haileyesus ;

Sanne, Ian ;

Nunn, Paul .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (04) :423-430

[30] Isoniazid preventive therapy for tuberculosis in HIV-1-infected adults: Results of a randomized controlled trial [J].

Hawken, MP ;

Meme, HK ;

Elliott, LC ;

Chakaya, JM ;

Morris, JS ;

Githui, WA ;

Juma, ES ;

Odhiambo, JA ;

Thiongo, LN ;

Kimari, JN ;

Ngugi, EN ;

Bwayo, JJ ;

Gilks, CF ;

Plummer, FA ;

Porter, JDH ;

Nunn, PP ;

McAdam, PWJ .

AIDS, 1997, 11 (07) :875-882

← 1 2 3 4 5 6 7 →